Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT02125383 · ClinicalTrials.gov registry record · NA
ParkinStim: Transcranial Direct Current Stimulation for Parkinson's Disease
A NA study, sponsored by Great Lakes NeuroTechnologies.
- Completed
- Registry status
- NA
- Development phase
- 9
- Enrollment target
NCT02125383: Completed NA study, sponsored by Great Lakes NeuroTechnologies.
NCT02125383 is a NA study that has completed, run by Great Lakes NeuroTechnologies. The registered enrollment target is 9 participants, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (99% lower). According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT02125383, a NA study, has completed, sponsored by Great Lakes NeuroTechnologies.
- COMPLETED
- Registry status
- NA
- Development phase
- 9 participants
- Enrollment target
Study Summary
The purpose of this study is to evaluate the effects of transcranial direct current stimulation (tDCS) on patients with Parkinson's disease during sleep.
Primary Outcome
PD motor symptoms will be assessed for two days before (baseline) and two days after each tDCS sleep study using Kinesia HomeView. Changes for active tDCS will be compared to changes for sham tDCS.
Interventions
- PROCEDURE Sham tDCS
- PROCEDURE Active tDCS
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 9 participants |
| Start Date | 2014-04 |
| Est. Completion | 2015-02 |
| Phase | NA |
What the finished NCT02125383 record still lists
NCT02125383 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 9 participants, a relatively small participant target, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (99% lower).
The record links to 0 conditions, and to 2 interventions - of which Sham tDCS is the first listed.
NCT02125383 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT02125383 about?
NCT02125383 is a clinical study titled "ParkinStim: Transcranial Direct Current Stimulation for Parkinson's Disease". The purpose of this study is to evaluate the effects of transcranial direct current stimulation (tDCS) on patients with Parkinson's disease during sleep.
What is the current status of trial NCT02125383?
This trial is currently completed. It is a NA study. The enrollment target is 9 participants. The study started on 2014-04. Estimated completion is 2015-02.
What interventions are being tested in trial NCT02125383?
The interventions under investigation include: Sham tDCS (PROCEDURE), Active tDCS (PROCEDURE).
Who is sponsoring clinical trial NCT02125383?
This trial is sponsored by Great Lakes NeuroTechnologies, which has 17 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
How this trial's enrollment target compares
Where NCT02125383's enrollment target sits among peer trials
9 1975th of 2000 higher than 25 of 2,000 other NA trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other NA trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia